View drug registration information details.


ItemsRegistration information
ID218
No218
Brand NameBESIDX
IngredientsABEMACICLIB 150 MG
Dosage FormFILM COATED TABLET
Primary PackagingBOTTLE
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack SizeBOX OF 56'S/BOTTLE
Dispensing CategoryPRESCRIPTION
ATC Classification
Pharmaceutical ClassANTINEOPLASTIC
IndicationsTO TREAT CERTAIN TYPE OF HORMONE RECEPTOR POSITIVE, EARLY BREAST CANCER OR BREAST CANCER THAT HAS SPREAD TO OTHER PARTSOF THE BODY AFTER TREATMENT WITH AN ANTIESTROGEN MEDICATION SUCH AS TAMOXIFEN
Contraindications
Side Effects
Unit Price
EDL No
DescriptionLIGHT YELLOW TABLETS, LETTER DX ON ONE SIDE AND 150 ANOTHER SIDE
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 L 1097/24
FDD Registration Date2024-05-06
Expiry Date2027-05-05

Back to drug list